These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 8462230

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Controlled study of the putative interaction between famotidine and theophylline in patients with chronic obstructive pulmonary disease.
    Bachmann K, Sullivan TJ, Reese JH, Jauregui L, Miller K, Scott M, Yeh KC, Stepanavage M, King JD, Schwartz J.
    J Clin Pharmacol; 1995 May; 35(5):529-35. PubMed ID: 7657856
    [Abstract] [Full Text] [Related]

  • 3. Famotidine effects on theophylline pharmacokinetics in subjects affected by COPD. Comparison with cimetidine and placebo.
    Verdiani P, Di Carlo S, Baronti A.
    Chest; 1988 Oct; 94(4):807-10. PubMed ID: 3168576
    [Abstract] [Full Text] [Related]

  • 4. Comparative effect of famotidine and cimetidine on the pharmacokinetics of theophylline in normal volunteers.
    Lin JH, Chremos AN, Chiou R, Yeh KC, Williams R.
    Br J Clin Pharmacol; 1987 Nov; 24(5):669-72. PubMed ID: 2893637
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of theophylline and the H2-antagonist drugs cimetidine and ranitidine.
    Dal Negro R, Pomari C, Zoccatelli O, Trevisan F, Carloni C, Turco P.
    Int J Clin Pharmacol Ther Toxicol; 1984 Apr; 22(4):221-6. PubMed ID: 6325354
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Combined administration of controlled release theophylline and ranitidine: a 53-day controlled survey in patients with chronic obstructive lung disease (COLD) and peptic disease.
    Dal Negro R, Turco P, Pomari C, Trevisan F, De Conti F, Cordaro CI.
    Br J Clin Pract; 1987 Nov; 41(11):1004-8. PubMed ID: 3504314
    [No Abstract] [Full Text] [Related]

  • 8. Cimetidine-theophylline interaction: report of four patients.
    Bauman JH, Kimelblatt BJ, Caraccio TR, Silverman HM, Simon GI, Beck GJ.
    Ann Allergy; 1982 Feb; 48(2):100-2. PubMed ID: 6121526
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cimetidine-theophylline interaction in patients with chronic obstructive airways disease.
    Roberts RK, Grice J, McGuffie C.
    Med J Aust; 1984 Mar 03; 140(5):279-80. PubMed ID: 6700460
    [Abstract] [Full Text] [Related]

  • 12. The influence of orally administered cimetidine and theophylline on the elimination of each drug in patients with chronic airways obstruction.
    Hsu K, Garton A, Sproule BJ, Tam YK, Legatt D, Herbert FA.
    Am Rev Respir Dis; 1984 Nov 03; 130(5):740-3. PubMed ID: 6497156
    [Abstract] [Full Text] [Related]

  • 13. Cimetidine inhibits theophylline clearance in patients with chronic obstructive pulmonary disease: a study using stable isotope methodology during multiple oral dose administration.
    Vestal RE, Thummel KE, Musser B, Mercer GD.
    Br J Clin Pharmacol; 1983 Apr 03; 15(4):411-8. PubMed ID: 6849776
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics and pharmacodynamics of famotidine in paediatric patients.
    James LP, Kearns GL.
    Clin Pharmacokinet; 1996 Aug 03; 31(2):103-10. PubMed ID: 8853932
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.